NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/10/2025
Voltar para busca
Dado oficial do USPTO
BIFICOL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
17/02/2023
Data de registro
01/10/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/10/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
IT
Examinador
O'BRIEN, JENNIFER LYNN
Unidade examinadora
N30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
PROBIOTICAL S.P.A.
Representantes
Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Micro-organisms and cultures of micro-organismsin particular bacteria for use in food manufacturebifidobacterium probiotic bacteria for use in the manufacture of food supplementsfoodcosmeticsyeast nutrients for industrial purposes and fermented milk products in the nature of milk ferments for industrial purposes; micro-organisms and cultures of microorganismsin particular probiotic lactic bacteriaprobiotic bifidobacterium bacteria to be administered to human beings and reared animal speciesnot for medical or veterinary use for use in the manufacture of food supplementsfoodcosmetics; micro-organisms and concentrated cultures of probiotic micro-organisms in liquidsoliddried and freeze-dried formprobiotic bacteria for use in the manufacture of food supplementsfoodcosmetics
Classe 5
Micro-organisms and cultures of micro-organismsin particular probiotic preparations for medical use in the nature of probiotic lactic bacteriaprobiotic bifidobacterium bacteria to be administered to human beings and to reared animal speciesfor medical and veterinary use; micro-organisms and cultures of micro-organismsin particular probiotic preparations for medical use in the nature of probiotic lactic bacteriaprobiotic bifidobacterium bacteria capable of inducing a metabolic action able to affect cholesterol levels in blood; specialty pharmaceuticals containing micro-organisms and cultures of micro-organismsin particular probiotic preparations for medical use in the nature of probiotic lactic bacteriaprobiotic bifidobacterium bacteria for treating the intestinal bacterial florafor restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapyfor treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial florafor treating intestinal dismicrobic syndromesin particular in diseases linked to changes in the bacterial flora such as diarrheagastroenteritisnon-specific enteritiscolitisulcerous colitis and Crohn's diseasein the form of pharmaceuticals for oral applicationin particular capsulescompresssolutionssuspensionsgranulesgranulates in dried or freeze-dried formfood supplementsfood supplements for medical use containing micro-organisms and cultures of micro-organismsin particular probiotic lactic bacteriaprobiotic bifidobacterium bacteria to be administered to human beings; dietary supplements; food supplements containing microorganisms and cultures of microorganismsin particular probiotic lactic bacteriaprobiotic bifidobacterium bacteria to be administered to human beingsnot for medical use; symbiotic dietary supplements containing micro-organisms or cultures of micro-organismsin particular probiotic lactic bacteriaprobiotic bifidobacterium bacteria and prebiotic fibres
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/05/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/03/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/03/2025
FIMP
FINAL DISPOSITION PROCESSED
06/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/01/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
01/10/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
28/08/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
28/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/07/2024
PUBO
PUBLISHED FOR OPPOSITION
16/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
10/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/06/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
10/06/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2024
RFNT
REFUSAL PROCESSED BY IB
02/01/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/12/2023
RFRR
REFUSAL PROCESSED BY MPU
07/12/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/12/2023
CNRT
NON-FINAL ACTION WRITTEN
06/12/2023
DOCK
ASSIGNED TO EXAMINER
16/11/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/04/2023
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
31/03/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIFICOL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.